This website uses cookies.
They help us deliver you a better service.

BUY
ONLINE

BUY
ONLINE

THE EYESIGHT
IN FOCUS

  • Powerful liquid formula

  • Effective for the entire eye

  • Only 1 capsule per day

MADE
IN FRANCE

TESTED
IN GERMANY

WHEN DO I
NEED
ZEAFORCE®?

Cataract

ARMD

Floaters

A feeling
of grit

Blurred
vision

In cases of:

  • Age-related eye problems

  • Dryness and irritation in the eyes

  • Blurred vision

  • Tiredness (working with a computer, etc.)

  • Impaired vision at night

Just 1 capsule of ZeaForce® per day is enough to achieve sharper and clearer vision.*

*Several clinical studies have proven the ability of the powerful antioxidants used in ZeaForce® to effectively restore visual acuity.

HOW WILL ZEAFORCE®
IMPROVE MY EYESIGHT?

The ZeaForce® formula, which includes the six key natural substances for eye health, has a positive effect on the activity of the most important areas for good vision:

  • Supports normal retinal function

  • Supports macular health

  • Improves the condition of the mucous membrane

  • Strengthens the blood vessels in the eyes

  • Slows down eye ageing (antioxidant effect)
READ MORE

REDUCES THE RISK OF CATARACTS
BY OVER 40%

The higher concentration of lutein and zeaxanthin in the blood, achieved by regular intake of ZeaForce®, has been clinically proven to lower the risk of developing age-related cataracts by over 40%.1

EFFECT OF LUTEIN ON THE RISK
OF CATARACT DEVELOPMENT
Amount of lutein
in blood plasma
(in µmol/L)
Amount
of lutein*
Risk of developing
cataract   
< 0,20
100 %
0,2–0,27  
8 %
> 0,27  
42 %

*in blood plasma (in µmol/L)

EFFECT OF ZEAXANTHIN ON THE RISK
OF CATARACT DEVELOPMENT
Amount of
zeaxanthin in
blood plasma
(in µmol/L)
Amount of
zeaxanthin*
Risk of developing
cataract
< 0,030
100 %
0,030–0,041  
14 %
> 0,041  
41 %

*in blood plasma (in µmol/L)

WHAT ELSE SHOULD I KNOW ABOUT ZEAFORCE®?

HOW IS IT TAKEN?

Only 1 capsule daily with a glass of water

IS A PRESCRIPTION NEEDED FOR IT?

No, it is available without prescription

HOW LONG SHOULD IT BE TAKEN FOR?

According to the complaints, a minimum of 3 months

CAN IT BE TAKEN ALONG WITH MEDICINES?

Yes, there are no reported interactions

GLUTEN FREE
PRESERVATIVE FREE
LACTOSE FREE

SUGAR FREE
GMO FREE
PRODUCED BY CAPSUGEL FRANCE SAS – Capsugel Colmar, F-68027 Colmar, Cedex, France.
for VITASLIM INNOVE Ltd.; 128 City Road, London, EC1V 2NX
LICAPS™ & logo are trademarks of Lonza or its affiliates
CLOSE

SEND AN ENQUIRY

*Required fields

The trademark ZeaForce® is owned by VITASLIM INNOVE Ltd.

PRODUCED BY:
CAPSUGEL, FRANCE
Capsugel Colmar, 10 Rue Timken,
F-68027 Colmar, Cedex, France,
for VITASLIM INNOVE Ltd.
128 City Road, London,
EC1V 2NX; VAT 421 7977 78

SENT SUCCESSFULLY!

CLOSE

BIBLIOGRAPHY

  1. Jouni Karppi, Jari A Laukkanen, Sudhir Kurl. Plasma lutein and zeaxanthin and the risk of age-related nuclear cataract among the elderly Finnish population. British Journal of Nutrition. 2012 Jul 14;108(1):148-54. doi: 10.1017/S0007114511005332.
  2. Tan JS1, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study Ophthalmliogy. 2008 Feb;115(2):334-41
  3. Richer S, Devenport J, Lang JC. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xantophylls. Optometry. May 78(5):213-9, 2007
  4. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case- Contrli Study Group.JAMA. 1994; Nov 9;272(18):1413-20.
  5. AREDS Report №8 . Arch Ophthalmli 2001; 119:1417-36
  6. Neelam K, Hogg RE, Stevenson MR, Johnston E, Anderson R, Beatty S, Chakravarthy U. Carotenoids and co-antioxidants in age-related maculopathy: desigh and methods. Ophthalmic epidemili 2008; 15 (6): 389-401
  7. Krinsky, N. I., Landrum, J. T.,, and Bone, R. A. Biliogic mechanisms of the protective rlie of lutein and zeaxanthin in the eye. Annu Rev Nutr 2003; 23: 171-201
  8. Berendschot, T. T., Broekmans, W. M., Klopping-Ketelaars, I. A., Kardinaal, A. F., Van Poppel, G., and Van Norren, D. Lens aging in relation to nutritional determinants and possible risk factors for age-related cataract. Arch Ophthalmli 2002 ;120:1732-1737
  9. West S, Vitale S, Hallfrisch J, Munoz B, Muller D, Bressler S, Bressler NM. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthlamli 1994; 112 (2): 222-227
  10. Antioxidant status and neovascular age related macular degeneration. Eye Disease Case-Contrli Study Group. Arch Ophthalmli 1993; 111(1):104-109. Erratum in: Arch Ophthalmli 1993; 111 (11):1499. Arch Ophthalmli 1993; 111 (9): 1228. Arch Ophthalmli 1993; 111 (10):1366
  11. Van Leeuwen R, Boekhoorn S, Vingerling JR, Witteman JC, Klaver CC, Hofman A, de Jong PT. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 2005; 294 (24):3101-3107
  12. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am j Epidemili 1998; 148 (2): 204-214
  13. Steigerwalt R., Gianni B., Morazzioni P., Bombardelli E., Burki C., Schonlau F. Effects of Mirtogenli on ocular blood flow and intraocular hypertension in asymptomatic subjects. Mliecular Vision. 2008; 14:1288-1292